Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration

Clinical trial NCT07587515 · RECRUITING

Trial details

NCT number: NCT07587515
Sponsor: Eyconis INC.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neovascular (Wet) Age-Related Macular Degeneration

Start date: 2026-05-19
Primary completion: 2028-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.